1. Epigenetic modulation of immune synaptic-cytoskeletal networks potentiates γδ T cell-mediated cytotoxicity in lung cancer.
- Author
-
Weng RR, Lu HH, Lin CT, Fan CC, Lin RS, Huang TC, Lin SY, Huang YJ, Juan YH, Wu YC, Hung ZC, Liu C, Lin XH, Hsieh WC, Chiu TY, Liao JC, Chiu YL, Chen SY, Yu CJ, and Tsai HC
- Subjects
- Actin Cytoskeleton drug effects, Actin Cytoskeleton metabolism, Animals, Cell Line, Tumor, Cytoskeleton drug effects, Cytotoxicity, Immunologic drug effects, DNA (Cytosine-5-)-Methyltransferases antagonists & inhibitors, DNA (Cytosine-5-)-Methyltransferases metabolism, Decitabine pharmacology, Enzyme Inhibitors pharmacology, Gene Expression Regulation, Neoplastic drug effects, Humans, Immunological Synapses drug effects, Isotope Labeling, Lymphocyte Activation drug effects, Lymphocyte Activation genetics, Lymphocyte Subsets drug effects, Lymphocyte Subsets metabolism, Male, Mice, Inbred NOD, Phosphotyrosine metabolism, RNA, Messenger genetics, RNA, Messenger metabolism, Survival Analysis, Tumor Suppressor Protein p53 metabolism, Up-Regulation drug effects, Xenograft Model Antitumor Assays, Mice, Cytoskeleton metabolism, Cytotoxicity, Immunologic genetics, Epigenesis, Genetic drug effects, Immunological Synapses genetics, Lung Neoplasms genetics, Lung Neoplasms immunology, Receptors, Antigen, T-Cell, gamma-delta metabolism
- Abstract
γδ T cells are a distinct subgroup of T cells that bridge the innate and adaptive immune system and can attack cancer cells in an MHC-unrestricted manner. Trials of adoptive γδ T cell transfer in solid tumors have had limited success. Here, we show that DNA methyltransferase inhibitors (DNMTis) upregulate surface molecules on cancer cells related to γδ T cell activation using quantitative surface proteomics. DNMTi treatment of human lung cancer potentiates tumor lysis by ex vivo-expanded Vδ1-enriched γδ T cells. Mechanistically, DNMTi enhances immune synapse formation and mediates cytoskeletal reorganization via coordinated alterations of DNA methylation and chromatin accessibility. Genetic depletion of adhesion molecules or pharmacological inhibition of actin polymerization abolishes the potentiating effect of DNMTi. Clinically, the DNMTi-associated cytoskeleton signature stratifies lung cancer patients prognostically. These results support a combinatorial strategy of DNMTis and γδ T cell-based immunotherapy in lung cancer management.
- Published
- 2021
- Full Text
- View/download PDF